Kinetics of human butyrylcholinesterase inhibition by 1,9-dimethyl-methylene blue

Kinetics of human butyrylcholinesterase inhibition by 1,9-dimethyl-methylene blue

Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disorder, characterized by β-amyloid plaques, neurofibrillary tangles and loss of cholinergic neurons. Butyrylcholinesterase (BChE) inhibition is one of the most critical strategy for the treatment of AD since BChE causes...

Full description

Bibliographic Details
Main Author: Kevser BIBEROGLU
Format: Article
Language:English
Published: Turkish Chemical Society 2021-05-01
Series:Journal of the Turkish Chemical Society, Section A: Chemistry
Subjects:
alzheimer’s disease
butyrylcholinesterase
1
9-dimethyl-methylene blue
cholinesterase inhibition
phenothiazine
Online Access:https://dergipark.org.tr/tr/pub/jotcsa/issue/60129/853598

Internet

https://dergipark.org.tr/tr/pub/jotcsa/issue/60129/853598

Similar Items